The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer by Masatsune Shibutani et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY
Shibutani et al. World Journal of Surgical Oncology  (2015) 13:194 
DOI 10.1186/s12957-015-0609-3RESEARCH Open AccessThe prognostic significance of a
postoperative systemic inflammatory
response in patients with colorectal cancer
Masatsune Shibutani*, Kiyoshi Maeda, Hisashi Nagahara, Hiroshi Ohtani, Yasuhito Iseki, Tetsuro Ikeya,
Kenji Sugano and Kosei HirakawaAbstract
Background: Recently, a preoperative systemic inflammatory response has been reported to be a prognostic factor
in patients with colorectal cancer (CRC). However, the prognostic significance of a systemic inflammatory response
in the early stage after surgery in patients with CRC is unknown. The aim of this retrospective study was to evaluate
the prognostic significance of a postoperative systemic inflammatory response in patients with CRC.
Methods: Two hundred and fifty-four patients who underwent potentially curative surgery for stage II/III CRC were
enrolled in this study. Univariate and multivariate analyses were performed to evaluate the relationship between
the prognosis and clinicopathological factors, including the neutrophil-to-lymphocyte ratio (NLR) and Glasgow
Prognostic Score (GPS), which were measured within two weeks before operation and at the first visit after leaving
the hospital.
Results: The overall survival rates were significantly worse in the high preoperative NLR/preoperative GPS/postoperative
NLR group. A multivariate analysis indicated that only preoperative GPS, postoperative NLR, and the number of lymph
node metastases were independent prognostic factors for a poor survival.
Conclusions: The postoperative NLR is an independent prognostic factor in patients with CRC who underwent
potentially curative surgery.
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Colorectal cancer (CRC) is the third leading cause of
cancer death worldwide [1]. Although the surgical pro-
cedures and chemotherapy have improved, a large num-
ber of patients relapse after curative resection, and the
mortality from colorectal cancer is still high. Therefore,
it is necessary to identify the patients with a high possi-
bility of recurrence, and various biomarkers associated
with poor survival have been examined.
Recently, the systemic inflammatory response has been
recognized to correlate with the progression of the tumor
and the prognosis of various types of cancer, including
CRC. The markers of the systemic inflammatory response,* Correspondence: fbxbj429@ybb.ne.jp
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creativecommons.org/publicdomain/zero/1.0/such as the neutrophil-to-lymphocyte ratio (NLR) [2–4],
serum C-reactive protein (CRP) level [5, 6], and Glasgow
prognostic score (GPS) [4, 7, 8] have been reported to be
associated with the prognosis in patients with CRC. How-
ever, most of these reports investigated the preoperative
status, and there have been no reports on the relationship
between the systemic inflammatory response in the early
stage after surgery and the prognosis after potentially
curative resection of CRC. The aim of this retrospective
study was to evaluate the prognostic significance of the
postoperative systemic inflammatory response in patients
with CRC.Methods
We retrospectively reviewed a database of 254 patients
who underwent potentially curative surgery for stage II/
III CRC at the Department of Surgical Oncology ofarticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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surgery was defined as the absence of any gross residual
tumor tissue in the surgical bed, with a surgical resec-
tion margin that was pathologically negative for tumor
invasion. Patients who received preoperative therapy or
who had either bowel obstruction or perforation due to
their primary tumor were excluded from the analysis.
The patient population consisted of 139 males and 115
females, with a median age of 60 years (range, 26 to 86).
One hundred and thirty-one patients had tumors located
in the colon, and 123 had tumors located in the rectum.
One hundred and seventy-eight patients received mono-
therapy using an oral pro-drug based on 5-FU, such as
capecitabine, while 30 patients received combination ther-
apy with 5-FU and oxaliplatin, such as 5-fluorouracil/leu-
covorin plus oxaliplatin (FOLFOX) or capecitabine plus
oxaliplatin (CapeOX) (Table 1).
The postoperative systemic inflammatory response was
measured at the first visit after leaving the hospital. The
date of the first visit was set to occur two to three weeks
after the patient left the hospital. The median (interquar-
tile range) period from the operation until the first visit
after leaving the hospital was 29 (23–36) days. The NLR
was calculated from a blood sample by dividing the abso-
lute neutrophil count by the absolute lymphocyte count.
According to the receiver-operating characteristic (ROC)
curve, we set 2.5 as the cut-off value for the preoperative
NLR (the sensitivity was 51.9 % and the specificity was
64.2 %) (Fig. 1a) and classified the patients into high pre-
operative NLR (≥2.5) and low preoperative NLR (<2.5)
groups. Moreover, according to the ROC curve, we also
set 3.0 as the cut-off value for the postoperative NLR (the
sensitivity was 35.7 % and the specificity was 87.3 %)
(Fig. 1b) and classified the patients into high postoperative
NLR (≥3.0) and low-postoperative NLR (<3.0) groups.
We defined the GPS according to the previous reports
as follows [9]: the GPS consists of the combination of an
elevated CRP (≥1 mg/dl) and hypoalbuminemia (<3.5 g/
dl). Patients with both abnormalities were allocated a GPS
of 2. Patients with only one of these abnormalities were al-
located a GPS of 1. Patients with normal values for both
were allocated a GPS of 0. The patients with a GPS of 1 or
2 were classified into the high GPS group, and those with
a GPS of 0 were classified into the low-GPS group.
We then examined the correlations between the clini-
copathological parameters, including the postoperative
NLR/GPS and the prognosis for survival. All patients
were followed up regularly with physical and blood ex-
aminations and mandatory screening using colonoscopy
and computed tomography until May 2014 or death.
Among the total 254 patients, 86 developed recurrent
disease and 42 patients died.
The resected specimens were pathologically classified
according to the seventh edition of the Union forInternational Cancer Control TNM classification of ma-
lignant tumors [10]. The significance of the correlations
between the systemic inflammatory response and the
clinicopathological characteristics was analyzed by the χ2
test, Fisher’s exact test, and t-test. The duration of sur-
vival was calculated according to the Kaplan-Meier
method. Differences in the survival curves were assessed
with the log-rank test. A multivariate analysis was per-
formed according to the Cox proportional hazards model.
All statistical analyses were conducted using the SPSS soft-
ware package for Windows (SPSS Japan, Tokyo, Japan).
Statistical significance was set at a value of p <0.05.
Results
The preoperative/postoperative indicators of a systemic
inflammatory response are shown in Table 1. The distri-
bution of patients based on the indicators of a systemic
inflammatory response is shown in Table 2.
As for the preoperative inflammatory status, an assess-
ment of the prognosis showed that the overall survival
rates were significantly worse in the high preoperative
NLR/GPS group (NLR, p = 0.0388; GPS, p = 0.0028)
(Fig. 2). Moreover, as for the postoperative inflammatory
status, the overall survival rates were significantly worse
in the high postoperative NLR group (p = 0.0006), while
there was no relationship between the postoperative
GPS and mortality (Fig. 3). The postoperative NLR had a
significant relationship with the amount of blood loss
during the operation and the length of the operation and
tended to correlated with gender, while there was no rela-
tionship between the postoperative NLR and other factors
including preoperative NLR (Table 3). The postoperative
GPS had a significant relationship with lymphatic involve-
ment, the number of lymph node metastasis, the preopera-
tive CA19-9 level, and the preoperative GPS (Table 3).
With regard to the relationships between the postoperative
systemic inflammatory response and the sub-classification
of the postoperative infectious complications, neither NLR
nor GPS showed a significant relationship with the sub-
classification of the postoperative infectious complications
(Table 4).
The correlations between the overall survival and vari-
ous clinicopathological factors are shown in Table 5. Ac-
cording to a univariate analysis, the overall survival had
significant relationships with the postoperative NLR, the
preoperative NLR, the preoperative GPS, age, the tumor
depth, histological type, venous involvement, and the
number of lymph node metastases. However, a multi-
variate analysis indicated that only the preoperative GPS,
the postoperative NLR, and the number of lymph node
metastases were independent risk factors for mortality.
We categorized the patients into four groups accord-
ing to the combination of their preoperative and postop-
erative NLR. Patients with the low preoperative and
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Median value of indicators of the preoperative
systemic inflammatory response (range)
NLR 2.26 (0.87–10.24)
CRP (mg/dl) 0.11 (0.01–13.99)
Preoperative serum albumin level (g/dl)
Median (range) 4.1 (2.6–4.8)
Median value of indicators of the postoperative
systemic inflammatory response (range)
NLR 1.82 (0.18–10.11)
CRP (mg/dl) 0.09 (0.01–17.09)
Postoperative serum albumin level (g/dl)
Median (range) 4.0 (3.0–4.7)
Table 1 The patient characteristics (Continued)
The number of days from operation until the first
visit after leaving the hospital
Median (interquartile range) 29 (23–36)
5-FU 5-fluorouracil, CapeOX capecitabine plus oxaliplatin, FOLFOX 5-fluorouracil/
leucovorin plus oxaliplatin, NLR neutrophil-to-lymphocyte ratio, CRP C-reactive
protein
Fig. 1 a Receiver-operating characteristic-curve analysis of the
preoperative NLR. Area under the curve = 0.618, 95 % confidence
interval = 0.502–0.735, p = 0.053. b Receiver-operating characteristic-
curve analysis of the postoperative NLR. Area under the curve =
0.680, 95 % confidence interval = 0.573–0.787, p = 0.002
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Table 2 The distribution of patients based on the indicators of
the postoperative systemic inflammatory response
Preoperation Postoperation
NLR
Low 99 (61.5 %) 183 (84.3 %)
High 62 (38.5 %) 34 (15.7 %)
GPS
0 174 (77.7 %) 159 (77.6 %)
1 44 (19.6 %) 39 (19.0 %)
2 6 (2.7 %) 7 (3.4 %)
NLR neutrophil-to-lymphocyte ratio, GPS Glasgow prognostic score
Fig. 2 a The overall survival according to the preoperative NLR. The
overall survival rates were significantly worse in the high preoperative
NLR group (p = 0.0388). b The overall survival according to the
preoperative GPS. The overall survival rates were significantly worse in
the high preoperative GPS group (p = 0.0028)
Fig. 3 a The overall survival according to the postoperative NLR. The
overall survival rates were significantly worse in the high postoperative
NLR group (p = 0.0006). b The overall survival according to the
postoperative GPS. There was no relationship between the
postoperative GPS and mortality
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with the low preoperative NLR and the high postopera-
tive NLR were categorized into group B. Patients with
the high preoperative NLR and the low-postoperative
NLR were categorized into group C. Patients with the
high preoperative and postoperative NLR categorized into
group D. The patients in group A exhibited a better prog-
nosis compared to the other groups (AvsB, p = 0.0124;
AvsC, p = 0.0202; AvsD, p = 0.0031), while there was no
significant difference between groups B, C, and D with re-
gard to survival (Fig. 4).
Discussion
In this study, we investigated the correlations between
the high postoperative NLR and poor survival in patients
with colorectal cancer who underwent potentially curative
Table 3 The correlation between the postoperative systemic inflammatory response and the clinicopathological factors
Postoperative NLR Postoperative GPS
<3 ≥3 p value 0 1,2 p value
Age (years)
<70 120 19 102 28
≥70 63 15 0.331 57 18 0.729
Gender
Male 97 24 84 27
Female 86 10 0.063 75 19 0.506
Location
Colon 93 19 86 22
Rectum 90 15 0.709 73 24 0.504
Tumor depth
T1-3 133 22 112 33
T4 49 12 0.406 47 13 1.000
Histological type
Well, moderately 170 31 147 43
Poorly, mucinous 12 3 0.711 12 2 0.739
Lymphatic involvement
Negative 39 5 35 3
Positive 124 27 0.363 112 37 0.026
Venous involvement
Negative 123 24 109 35
Positive 46 9 1.000 41 8 0.321
Number of lymph node metastases
0 75 8 60 7
1–3 71 19 64 30
≥4 37 7 0.116 35 9 0.005
Preoperative CEA (>5 ng/ml)
Negative 129 25 116 29
Positive 38 6 0.816 35 8 1.000
Preoperative CA19-9 (>37 U/ml)
Negative 158 28 145 33
Positive 5 2 0.298 3 4 0.031
Adjuvant chemotherapy
No 40 4 35 8
Yes 143 30 0.246 124 28 0.545
Length of operation (min)
Median (range) 199 (79–430) 230 (84–687) 0.010 203 (79–687) 206 (110–372) 0.681
Blood loss (ml)
Median (range) 80 (5–1785) 220 (10–2700) <0.001 80 (5–2700) 90 (10–1880) 0.495
Postoperative infectious complication
No 137 25 121 34
Yes 46 9 0.833 38 12 0.846
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Table 3 The correlation between the postoperative systemic inflammatory response and the clinicopathological factors (Continued)
Preoperative NLR
<2.5 70 12
≥2.5 45 8 1.000
Preoperative GPS
0 131 21
1,2 24 20 <0.001
NLR neutrophil-to-lymphocyte ratio, GPS Glasgow prognostic score, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9
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malignant tumors, the TNM-classification criteria [10],
which are factors related to the tumor and accurately re-
flect the prognosis, have been widely used. Recently, the
prognostic significance of the factors related to the host
based on the systemic inflammatory response, such as the
NLR, CRP, and GPS in patients with CRC, has been re-
ported [2–8]. However, most of the previous reportsTable 4 The correlation between the postoperative systemic
inflammatory response and the sub-classification of the
postoperative infectious complications
Postoperative NLR Postoperative GPS
<3 ≥3 p value 0 1,2 p value
Criteria according to
Clavien-Dindo classification
Without complication, grade I 131 21 113 33
Grade ≥II 50 13 0.223 45 13 1.000
Wound infection
No 168 33 150 41
Yes 15 1 0.477 9 5 0.315
Anastomotic leakage
No 171 31 149 42
Yes 12 3 0.710 10 4 0.521
Abdominal abscess
No 176 33 154 45
Yes 7 1 1.000 5 1 1.000
Enterocolitis
No 176 33 153 46
Yes 7 1 1.000 6 0 0.341
Pneumonia
No 183 33 158 46
Yes 0 1 0.157 1 0 1.000
Urinary tract infection
No 181 33 157 45
Yes 2 1 0.402 2 1 0.535
Duodenal perforation
No 183 33 158 46
Yes 0 1 0.157 1 0 1.000
NLR neutrophil-to-lymphocyte ratio, GPS Glasgow prognostic scorefocused on the preoperative status, and there have been
only a few reports which focused on the prognostic signifi-
cance of the postoperative systemic inflammatory re-
sponse. To the best of our knowledge, this is the first
study assessing the prognostic significance of the systemic
inflammatory response in the early stage after surgery.
Neutrophils play a key role in tumor progression, produ-
cing a number of ligands that induce tumor cell prolifera-
tion and invasion, and promoting tumor vascularization
by releasing proangiogenic chemokines and other factors
[11, 12]. As the main cause of recurrence after potentially
curative operation may be the growth of micrometastases
which had been established prior to resection [13], and be-
cause the continuous systemic inflammatory response cre-
ates a favorable environment for micrometastatic growth,
a persistently elevated level of neutrophils after surgery is
considered to correlate with the development of recur-
rence. In contrast, lymphocytes, which play an important
role in anti-tumor immunity, are a factor related to the
immune system of the host [14]. The absolute lymphocyte
count is assumed to reflect the degree of responsiveness of
a cancer patient’s whole immune system [15]. Therefore, a
decrease of lymphocytes is considered to correlate with re-
currence. Taken together, a persistently high NLR after
surgery means the continuation of an environment that is
favorable for recurrence. Thus, the postoperative status, as
well as the preoperative status of the host, is important
when considering the prognosis.
The mechanism of the persistent activation of the sys-
temic inflammatory response after surgery remains un-
clear. In this study, a high postoperative NLR was
significantly correlated with the amount of blood loss
during the operation and the length of the operation.
These results suggested that a high postoperative NLR
might be associated with higher surgical stress. However,
we could not conclude that the main cause of the per-
sistent elevation of the systemic inflammatory response
after the operation was surgical stress itself, because
other than the parameters of blood loss during the oper-
ation and the length of the operation, there are no useful
markers for evaluating the degree of surgical stress, and
the markers on their own were not sufficient to perform
an evaluation. On the other hand, the postoperative
NLR had no association with the factors related to the
Table 5 The correlations between the overall survival and various clinicopathological factors
Univariate analysis Multivariate analysis
Hazard ratio 95 % CI p value Hazard ratio 95 % CI p value
Age (>70 years) 2.113 1.142–3.911 0.017 0.912 0.204–4.083 0.904
Gender (Male) 0.684 0.361–1.295 0.243
Location of primary tumor (Colon) 0.749 0.404-1.389 0.360
Tumor depth (T4) 1.863 1.007–3.448 0.048 4.592 0.896–23.544 0.068
Histological type (Poorly, mucinous) 3.449 1.582–7.518 0.002 0 0 0.988
Lymphatic involvement (Positive) 2.744 0.839–8.979 0.095
Venous involvement (Positive) 2.102 1.080–4.093 0.029 0.350 0.068–1.800 0.209
Number of lymph node metastases 2.924 1.816–4.707 <0.001 14.677 2.571–83.779 0.003
Preoperative CEA (>5 ng/ml) 1.939 0.875–4.299 0.103
Preoperative CA19-9 (>37 U/ml) 1.298 0.176–9.586 0.798
Adjuvant chemotherapy (Yes) 0.332 0.080–1.384 0.130
Chemotherapy regimen (with oxaliplatin) 0.726 0.216–2.433 0.603
Postoperative NLR (>3.0) 3.597 1.643–7.875 0.001 15.713 1.590–155.227 0.018
Postoperative GPS (≥1) 1.982 0.933–4.208 0.075
Preoperative NLR (>2.5) 2.204 1.023–4.750 0.044 6.599 0.928–46.914 0.059
Preoperative GPS (≥1) 2.723 1.372–5.404 0.004 7.238 1.180–44.415 0.032
CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9, NLR neutrophil-to-lymphocyte ratio, CRP C-reactive protein, GPS Glasgow prognostic score
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ported to correlate with several factors related to the
tumor [2]. Moreover, the postoperative NLR had no rela-
tionship with the presence of postoperative infectious
complications, even when performing the additional
analyses regarding the degree and type of postoperative
infectious complications. There were some patients with
normal inflammatory marker levels at the first visit after
leaving the hospital who developed postoperative infectious
complications, while some patients with high postopera-
tive systemic inflammatory marker levels were discharged
without postoperative complications. The postoperativeFig. 4 The overall survival subdivided according to the preoperative
and postoperative NLR. The patients in group A exhibited a better
prognosis compared to the other groups (*p = 0.0124; **p = 0.0202;
***p = 0.0031)infectious complications may not be the main cause of
the high postoperative systemic inflammatory response at
the first visit after leaving the hospital. Aside from surgi-
cal stress and the postoperative infectious complications,
the response of the host to the micrometastatic lesion
has been reported to cause a persistently high postopera-
tive systemic inflammatory response [16]. However, it is
questionable whether the response to the micrometa-
static lesion and the response to the primary tumor are
equivalent.
Our results were in line with a study by Guthrie et al.,
which reported that the persistent elevation of the sys-
temic inflammatory response after surgery was corre-
lated with poor survival [16]. However, we obtained
different results in relation to the superiority of the post-
operative inflammatory markers. We found postopera-
tive NLR to be superior to the postoperative GPS, while
Guthrie et al. reported the opposite [16]. Moreover, the
timing of the valuation of the postoperative inflamma-
tory response differed between this study and the previ-
ous report. In this study the postoperative inflammatory
response was evaluated in the early stage after operation
(approximately 1–2 months after surgery, when we de-
cided the regimen of adjuvant chemotherapy), while in
the previous report, the inflammatory response was eval-
uated at 3–6 months after surgery [16].
There are some limitations associated with this study.
First, we evaluated a relatively small number of patients.
Second, the criteria for the first visit after leaving the
hospital were not uniform because this study was a
Shibutani et al. World Journal of Surgical Oncology  (2015) 13:194 Page 8 of 8retrospective study. Third, the appropriate timing for the
evaluation of the postoperative systemic inflammatory
response to predict the survival was unknown. Fourth,
the mechanism of the persistent elevation of the postop-
erative inflammatory response remains unclear. A large,
prospective study should therefore be performed to con-
firm our findings.
Conclusions
In this study, the postoperative NLR was demonstrated
to correlate with a poor survival as well as the preopera-
tive NLR and the postoperative NLR were investigated
to be an independent prognostic factor for poor survival.
Therefore, not only the preoperative status of the host,
but also the postoperative status of the host, is import-
ant when considering the prognosis.
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